Patient characteristics
| Characteristic . | Total N = 82 (100%) . |
|---|---|
| Sex | |
| Male | 59 (71.9%) |
| Female | 23 (27.1%) |
| Age, y | |
| Median (range) | 22.7 (16.6-38.8) |
| 15-29 | 62 (75.6%) |
| ≥30-38 | 20 (24.4%) |
| BMI, kg/m2 | |
| Mean (range) | 25.9 (14.9-50.6) |
| <30 | 66 (80.5%) |
| ≥30 | 16 (19.5%) |
| ECOG performance status | |
| 0 | 38 (46.3%) |
| 1 | 36 (43.9%) |
| 2 | 8 (9.8%) |
| Immunophenotype | |
| B | 57 (69.5%) |
| T | 23 (28.0%) |
| Unknown | 2 (2.5%) |
| CNS disease | |
| Yes | 8 (9.8%) |
| No | 72 (87.8%) |
| Not assessed/unknown | 2 (2.4%) |
| Presenting WBC, ×109/L | |
| Median (range) | 8.5 (0.4-608) |
| ≥30 | 19 (23.3%) |
| <30 | 63 (76.8%) |
| Day 79 risk stratification* | |
| SR | 10 (13.9%) |
| MR | 23 (31.9%) |
| MHR | 11 (15.3%) |
| HR | 0 (0.0%) |
| VHR | 26 (36.1%) |
| Unknown | 2 (2.8%) |
| Karyotype | |
| t4;11 (q21;q23)† | 6 (7.3%) |
| Characteristic . | Total N = 82 (100%) . |
|---|---|
| Sex | |
| Male | 59 (71.9%) |
| Female | 23 (27.1%) |
| Age, y | |
| Median (range) | 22.7 (16.6-38.8) |
| 15-29 | 62 (75.6%) |
| ≥30-38 | 20 (24.4%) |
| BMI, kg/m2 | |
| Mean (range) | 25.9 (14.9-50.6) |
| <30 | 66 (80.5%) |
| ≥30 | 16 (19.5%) |
| ECOG performance status | |
| 0 | 38 (46.3%) |
| 1 | 36 (43.9%) |
| 2 | 8 (9.8%) |
| Immunophenotype | |
| B | 57 (69.5%) |
| T | 23 (28.0%) |
| Unknown | 2 (2.5%) |
| CNS disease | |
| Yes | 8 (9.8%) |
| No | 72 (87.8%) |
| Not assessed/unknown | 2 (2.4%) |
| Presenting WBC, ×109/L | |
| Median (range) | 8.5 (0.4-608) |
| ≥30 | 19 (23.3%) |
| <30 | 63 (76.8%) |
| Day 79 risk stratification* | |
| SR | 10 (13.9%) |
| MR | 23 (31.9%) |
| MHR | 11 (15.3%) |
| HR | 0 (0.0%) |
| VHR | 26 (36.1%) |
| Unknown | 2 (2.8%) |
| Karyotype | |
| t4;11 (q21;q23)† | 6 (7.3%) |